There are plenty of people who like the idea of having cosmetic procedures, but don’t like the idea of taking weeks off work and dealing with a prolonged recovery time. “If it were as easy as getting you hair done,” think many prospective cosmetic surgery patients, “I would do it.”
Today there actually are procedures that are as easy as getting your hair done – easier in some cases. Procedures like Botox injection, injection of fillers like Juvederm and Restylane, and even a form of “lunch hour breast augmentation” are readily available in the UK. And with the more invasive procedures like facelifts, surgeons are increasingly using what is called “twilight sleep” to anesthetize patients rather than using general anesthesia.
Botox injection is the most popular cosmetic procedure in the world, and it is little wonder why. With a cost in the mid-hundreds of pounds rather than thousands, it is affordable to a large section of the population, it is quick, and in the hands of a skilled practitioner, it can make a genuine difference in a person’s appearance. The same is true of the new temporary facial fillers that are often used alongside Botox to plump up wrinkles. Theoretically, a person could go to work looking 40 and come home from work looking 35 and feeling for the most part just fine.
Macrolane is a new procedure that is sometimes nicknamed the “boob jab” rather than boob
job because it does not involve cutting open the breast to implant a saline or silicone implant. Macrolane is a large scale version of fillers like Restylane, and it is injected into the breasts via cannula using local anesthesia. It is not unreasonable to expect an increase of one cup size with Macrolane injection. Rather than the dramatic effect that is achieved with silicone or saline implants, the effect with Macrolane is more one of swelling – as if the daydream of eating a burrito and having it go to the breasts were true.
Macrolane is also used to add shape to buttocks and calves, and men are recipients of these services as well as women. Though it has not been on the market for very long, the risks of Macrolane are believed to be lower than the risks of traditional implant surgery. One major reason is that the patient doesn’t have to undergo general anesthesia and assume the risks that it poses.
While many women in the U.S. are interested in Macrolane, it has not yet been approved by the Food and Drug Administration, but it is available in the U.K. and on the European continent.
About the Author
Leonard Dawson is a freelance article writer who writes for Cosmetic Surgery Guru about current issues, technology and news within the cosmetic surgery market.</p